Developing an asymptomatic mucosal herpes vaccine: the present and the future

Author： Dasgupta Gargi   Nesburn Anthony B   Wechsler Steven L   BenMohamed Lbachir  

Publisher： Future Medicine

ISSN： 1746-0913

Source： Future Microbiology, Vol.5, Iss.1, 2010-01, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tularemia vaccine: past, present and future

By Oyston Petra C.F.  

Antonie van Leeuwenhoek, Vol. 87, Iss. 4, 2005-05 ,pp. : 277-281

Springer Publishing Company

Access to resources Recommend Favorite

Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapy

By McGowin Chris L   Pyles Richard B  

Future Microbiology, Vol. 5, Iss. 1, 2010-01 ,pp. : 15-22

Future Medicine

Access to resources Recommend Favorite

Bacterial interplay at intestinal mucosal surfaces: implications for vaccine development

By Autenrieth I.B.   Schmidt M.A.  

Trends in Microbiology, Vol. 8, Iss. 10, 2000-10 ,pp. : 457-464

Elsevier

Access to resources Recommend Favorite

The -lactam antibiotics: past, present, and future

By Demain A.L.  

Antonie van Leeuwenhoek, Vol. 75, Iss. 1-2, 1999-02 ,pp. : 5-19

Springer Publishing Company

Access to resources Recommend Favorite

“Lignocellulose Biotechnology: Present and Future Prospects”

By  

World Journal of Microbiology and Biotechnology, Vol. 17, Iss. 6, 2001-08 ,pp. : 657-657

Springer Publishing Company

Access to resources Recommend Favorite